Lupin to acquire diabetes brands Ondero, Ondero-Met from Boehringer Ingelheim for Rs 207 crore Ruchika Sharma25 Aug 2022 3:30 PM ISTNew Delhi: Lupin Limited is soon going to acquire two diabetes brands Ondero and Ondero - Met from Boehringer Ingelheim International GmbH for Rs...
Novartis Sandoz division to go independent Ruchika Sharma25 Aug 2022 2:33 PM ISTThe standalone Sandoz would be headquartered in Switzerland and listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in...
Dr Vivek Srivastava onboarded as Senior Vice President of Zeon Lifesciences Ruchika Sharma25 Aug 2022 1:30 PM ISTNew Delhi: Zeon Lifesciences, Indian manufacturer of nutraceuticals and herbal products announced the onboarding of Dr. Vivek Srivastava as a...
Lupin, I'rom ink pact for biosimilar Denosumab Ruchika Sharma25 Aug 2022 12:30 PM ISTCurrently, Denosumab is available under two brands, Pralia and Ranmark.
Glenmark Pharma North Carolina facility gets USFDA OAI status Ruchika Sharma25 Aug 2022 11:55 AM ISTMumbai: Glenmark Pharmaceuticals Limited has recently announced that the company has received Official Action Indicated (OAI) status from the US Food...
Lupin gets USFDA nod for generic equivalent of Mylan Specialty Perforomist Inhalation Solution Ruchika Sharma24 Aug 2022 5:00 PM ISTPERFOROMIST Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist)
COVID vaccine 73.2 percent effective in children under 5: Pfizer Ruchika Sharma24 Aug 2022 4:30 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Bharat Biotech rotavirus oral vaccine ROTAVAC introduced in Nigeria for children Ruchika Sharma24 Aug 2022 3:30 PM ISTRotavirus is one of the leading causes of diarrheal disease in the world and is responsible for over 40% of diarrhoea in children.
AstraZeneca may not stay in vaccine business in long run: CEO Ruchika Sharma24 Aug 2022 2:57 PM ISTAstraZeneca is also looking for bolt-on acquisitions, including small and mid-sized companies specialising in oncology and cardiovascular treatments,...
Moderna seeks USFDA nod for COVID booster tailored against Omicron subvariants Ruchika Sharma24 Aug 2022 1:15 PM ISTThe submission also includes clinical trial data for its BA.1 Omicron-targeting bivalent booster candidate, which was last week cleared in Britain.
Aurobindo Pharma arm bags USFDA nod for Medroxyprogesterone Acetate Injectable Suspension Ruchika Sharma24 Aug 2022 12:25 PM ISTHyderabad: Drugmaker, Aurobindo Pharma Limited, today announced that its wholly-owned subsidiary company, Eugia Pharma Specialties Limited, has...
Merck Investigational Anticoagulant Therapy MK-2060 gets USFDA fast track designation Ruchika Sharma24 Aug 2022 11:27 AM ISTMK-2060 is a novel inhibitor of Factor XI being investigated for the prevention of thrombosis in patients with end-stage renal disease (ESRD).
